Healthcare
ByIs Viz.ai Transforming Medical Diagnostics and Acute Care with AI, Driving Global Adoption and Strategic Health System Collaboration?
Executive Summary Viz.ai, a leader in AI‑enabled clinical diagnostics and workflow orchestration, is reshaping how acute care conditions—especially…
Is NVIDIA Powering the AI Revolution in Medical Diagnostics as Healthcare Partners Commit to Next‑Gen Intelligence Platforms?
Executive Summary NVIDIA, the global leader in accelerated computing and AI infrastructure, is increasingly at the core of…
Did NVIDIA Become the Central AI Catalyst for Biopharma in 2025—And Which Players Benefited Most?
2025 marked a pivotal year for artificial intelligence in biopharma. As life sciences companies moved beyond isolated AI…
Which AI Biopharma Startups Truly Won in 2025—And How Did NVIDIA, Big Pharma Collaborations, and Deal Value Define Success?
Executive Perspective 2025 marked a decisive shift for AI biopharma startups—from experimental promise to measurable strategic impact. Success…
Can Localized Manufacturing Shield Big Pharma from Trade Volatility? Novartis Targets Zero U.S. Tariff Exposure by Mid-2026
23 January 2026 Executive Summary Novartis CEO Vas Narasimhan has outlined a decisive trade-risk mitigation strategy, stating that…
Is U.S. Manufacturing the Next Growth Hedge for Big Pharma? Novartis Commits $23 Billion to Domestic Expansion
23 January 2026 Executive Summary Novartis has unveiled a $23 billion investment plan to significantly expand its U.S.…
